Hyperfine (HYPR) vs LENSAR (LNSR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
LENSAR (LNSR) has outperformed Hyperfine (HYPR) over the past year, losing 47.0% versus a loss of 55.0%. Over five years, LNSR leads with a -14.2% price change compared with -90.5% for HYPR. Hyperfine is the larger company by market cap ($98.7 million vs $78.3 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HYPR | LNSR |
|---|---|---|
| Share price | $0.9307 | $6.37 |
| Market cap | $98.70M | $78.26M |
| 1-day change | -1.00% | -1.24% |
| YTD return | -3.97% | -44.54% |
| 1-year return | -55.02% | -47.04% |
| 5-year return | -90.54% | -14.23% |
| P/E ratio (TTM) | — | 35.39 |
| EPS (TTM) | $-0.37 | $0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.22 | $12.94 |
| 52-week low | $0.754 | $4.95 |
| Distance from 52-week high | -58.08% | -50.77% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +118.12% | +77.86% |
| Average volume | 765.15K | 102.04K |
| Shares outstanding | 90.99M | 12.29M |
| Employees | 102 | 150 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Hyperfine
HYPR stock →Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 102 employees
About LENSAR
LNSR stock →LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision.
Health Care · Medical/Dental Instruments · 150 employees
HYPR vs LNSR FAQ
Which is bigger, Hyperfine or LENSAR?
Hyperfine (HYPR) is larger, with a market capitalization of $98.70M compared with $78.26M for LENSAR (LNSR).
Which stock has performed better over the past year, HYPR or LNSR?
LNSR returned -47.04% over the past 12 months, compared with -55.02% for HYPR (price return, excluding dividends). Past performance does not predict future results.
Are Hyperfine and LENSAR in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for Hyperfine and Medical/Dental Instruments for LENSAR.